NovaQuest Private Equity (NQPE) has invested in Bend Bioscience, according to a news release.
Bend Bioscience, based in Bend, Ore., is an early-phase contract development and manufacturing organization (CDMO). Founded in 2021, the company specializes in particle engineering, drug delivery, drug development and manufacturing to the pharmaceutical industry.
NQPE is a private equity firm that invests in lower middle market healthcare services and technology companies primarily in North America. It’s the private equity group of NovaQuest Capital Management, which is based in Raleigh, N.C., and was formed in 2000.
As a result of the investment, the Bend Bioscience team is now part of CDMO CoreRx.
Terms of the investment were not disclosed.